A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines

BACKGROUND: Clinical success with chimeric antigen receptor (CAR)- based immunotherapy for leukemia has been accompanied by the associated finding that antigen-escape variants of the disease are responsible for relapse. To target hematologic malignancies with a chimeric antigen receptor (CAR) that t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Dina, Xiong, Ying, Wu, Darong, Nӧlle, Volker, Schmitz, Sarah, Haso, Waleed, Kaiser, Andrew, Dropulic, Boro, Orentas, Rimas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433150/
https://www.ncbi.nlm.nih.gov/pubmed/28515942
http://dx.doi.org/10.1186/s40425-017-0246-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433150/
https://www.ncbi.nlm.nih.gov/pubmed/28515942
http://dx.doi.org/10.1186/s40425-017-0246-1

Ejemplares similares